XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Dec 28, 2024 | (Q2)Sep 28, 2024 | (Q1)Jun 29, 2024 | (FY)Mar 30, 2024 | (Q4)Mar 30, 2024 | (Q3)Dec 30, 2023 | (Q2)Sep 23, 2023 | (Q1)Jun 24, 2023 | (FY)Mar 25, 2023 | (Q4)Mar 25, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -10.22%555.74M | 12.64%541.86M | 17.98%374.03M | -5.73%1.79B | -0.27%371.83M | 4.81%618.98M | -11.01%481.06M | -19.47%317.02M | 6.52%1.9B | -23.91%372.82M |
Operating revenue | -10.22%555.74M | 12.64%541.86M | 17.98%374.03M | -5.73%1.79B | -0.27%371.83M | 4.81%618.98M | -11.01%481.06M | -19.47%317.02M | 6.52%1.9B | -23.91%372.82M |
Cost of revenue | -14.45%257.95M | 10.58%259.27M | 17.43%185.1M | -7.21%872.82M | -3.90%179.2M | 2.60%301.52M | -12.93%234.47M | -17.47%157.63M | 9.65%940.64M | -19.36%186.47M |
Gross profit | -6.20%297.79M | 14.60%282.59M | 18.53%188.93M | -4.27%916.07M | 3.37%192.63M | 7.00%317.46M | -9.10%246.6M | -21.34%159.39M | 3.61%956.98M | -27.97%186.35M |
Operating expense | 1.16%152.02M | 8.81%150.74M | 0.38%142.13M | -6.69%570.65M | -8.22%140.25M | -3.25%150.28M | -10.67%138.53M | -4.56%141.59M | 9.73%611.56M | 1.29%152.8M |
Selling and administrative expenses | 3.82%39.04M | 10.17%37.81M | 3.93%36.77M | -5.86%144.17M | -2.06%36.87M | 0.92%37.6M | -13.32%34.32M | -8.44%35.38M | 1.42%153.14M | -4.63%37.64M |
Research and development costs | 0.27%112.98M | 8.37%112.93M | -0.80%105.36M | -6.97%426.48M | -10.23%103.38M | -4.57%112.67M | -9.76%104.21M | -3.19%106.22M | 12.82%458.41M | 3.38%115.16M |
Operating profit | -12.81%145.77M | 22.01%131.85M | 162.98%46.79M | 0.00%345.43M | 56.11%52.38M | 18.25%167.19M | -7.01%108.07M | -67.22%17.79M | -5.71%345.42M | -68.90%33.55M |
Net non-operating interest income expense | 66.62%8.15M | 118.13%8.13M | 78.30%8.2M | 126.46%20.58M | 55.93%7.36M | 76.05%4.89M | 190.19%3.73M | 1,408.20%4.6M | 1,377.56%9.09M | 4,682.52%4.72M |
Non-operating interest income | 63.23%8.36M | 110.93%8.38M | 74.76%8.42M | 115.25%21.49M | 53.48%7.58M | 71.09%5.12M | 159.95%3.97M | 821.22%4.82M | 538.84%9.99M | 4,193.91%4.94M |
Non-operating interest expense | -7.23%218K | 0.41%244K | 0.00%218K | 1.89%915K | 0.46%219K | 7.80%235K | 0.00%243K | 0.00%218K | -5.27%898K | 0.00%218K |
Other net income (expense) | -1,030.43%-214K | 100.80%19K | 326.79%1.61M | 97.93%-2.07M | 99.92%-78K | 100.62%23K | -909.83%-2.39M | -25.49%377K | -5,934.56%-99.77M | -53,908.89%-96.86M |
Special income (charges) | --0 | --0 | ---- | 97.97%-1.96M | --0 | --360K | ---2.32M | ---- | ---96.39M | ---96.39M |
-Less:Restructuring and merger&acquisition | --0 | --0 | ---- | -81.57%1.96M | --0 | ---360K | --2.32M | ---- | --10.63M | --10.63M |
-Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --85.76M | ---- |
Other non- operating income (expenses) | 36.50%-214K | 127.14%19K | 326.79%1.61M | 96.80%-108K | 83.19%-78K | 90.93%-337K | -123.73%-70K | -25.49%377K | -297.60%-3.38M | -357.78%-464K |
Income before tax | -10.69%153.7M | 27.97%140.01M | 148.59%56.6M | 42.87%363.94M | 201.83%59.66M | 22.54%172.1M | -7.12%109.41M | -58.67%22.77M | -30.90%254.74M | -154.28%-58.59M |
Income tax | 12.94%37.7M | 11.36%37.87M | 102.34%14.51M | 14.52%89.36M | 401.32%14.82M | -9.70%33.38M | 11.08%34M | -53.38%7.17M | 84.45%78.04M | -142.65%-4.92M |
Net income | -16.38%116.01M | 35.45%102.14M | 169.84%42.1M | 55.39%274.57M | 183.55%44.84M | 34.06%138.72M | -13.51%75.41M | -60.71%15.6M | -45.86%176.7M | -155.67%-53.67M |
Net income continuous Operations | -16.38%116.01M | 35.45%102.14M | 169.84%42.1M | 55.39%274.57M | 183.55%44.84M | 34.06%138.72M | -13.51%75.41M | -60.71%15.6M | -45.86%176.7M | -155.67%-53.67M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -16.38%116.01M | 35.45%102.14M | 169.84%42.1M | 55.39%274.57M | 183.55%44.84M | 34.06%138.72M | -13.51%75.41M | -60.71%15.6M | -45.86%176.7M | -155.67%-53.67M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -16.38%116.01M | 35.45%102.14M | 169.84%42.1M | 55.39%274.57M | 183.55%44.84M | 34.06%138.72M | -13.51%75.41M | -60.71%15.6M | -45.86%176.7M | -155.67%-53.67M |
Basic earnings per share | -14.79%2.19 | 39.13%1.92 | 182.14%0.79 | 59.12%5.06 | 185.57%0.83 | 37.43%2.57 | -11.54%1.38 | -60.56%0.28 | -44.21%3.18 | -157.40%-0.97 |
Diluted earnings per share | -15.60%2.11 | 36.57%1.83 | 171.43%0.76 | 58.58%4.9 | 183.51%0.81 | 36.61%2.5 | -11.84%1.34 | -59.42%0.28 | -44.02%3.09 | -159.15%-0.97 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |